K3 Pharma Private Limited

Founded in 2022 and headquartered in Uttar Pradesh, India.

2022 | Kanpur Dehat, Uttar Pradesh (India) | Active
Last Updated: December 27, 2024

K3 Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024

About K3 Pharma

K3 Pharma Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 July 2022 (Two years and seven months 4 days old ). Its registered office is in Kanpur Dehat, Uttar Pradesh, India.

The Company is engaged in the Chemicals Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Sunil Gupta and Anjily Satyam serve as directors at the Company.

Company Details

  • Location

    Kanpur Dehat, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230UP2022PTC167434

  • Company No.

    167434

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    12 Jul 2022

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Chemicals
Pharmaceuticals

Who are the key members and board of directors at K3 Pharma?

Board Members (2)

Name Designation Appointment Date Status
Sunil Gupta Country flag representing In Director 12-Jul-2022 Current
Anjily Satyam Country flag representing In Director 12-Jul-2022 Current

Financial Performance of K3 Pharma.

Enhance accessibility to K3 Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of K3 Pharma?

Unlock access to K3 Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at K3 Pharma?

K3 Pharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of K3 Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K3 Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on K3 Pharma

Recent activity within the organization

  • Annual General Meeting

    K3 Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    K3 Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.

    31 Mar 2024

  • Director Appointment

    Sunil Kumar Gupta was appointed as a Director was appointed as a Director on 12 Jul 2022 & has been associated with this company since 2 years 7 months .

    12 Jul 2022

  • Director Appointment

    Anjily Satyam was appointed as a Director was appointed as a Director on 12 Jul 2022 & has been associated with this company since 2 years 7 months .

    12 Jul 2022

  • Company Incorporation

    K3 Pharma Private Limited was registered on 12 Jul 2022 with Roc Kanpur & aged 2 years 7 months as per MCA records.

    12 Jul 2022

Frequently asked questions

  • K3 Pharma Private Limited was incorporated on 12 Jul 2022.

  • The authorized share capital of K3 Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with K3 Pharma Private Limited.

    • Sunil Kumar Gupta
    • Anjily Satyam
  • As per Ministry of Corporate Affairs (Mca), the registered address of K3 Pharma Private Limited is 13/385 Ratan Orchid Civil Lines India, Kanpur, Uttar Pradesh, 208001.

  • The corporate identification number (CIN) of K3 Pharma Private Limited is U24230UP2022PTC167434 and the company number is 167434 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for K3 Pharma Private Limited was filed with the ROC on 31 Mar 2024.